Files and links (1)
Published (Version of Record)CC BY-NC-ND V4.0, Open Access
Journal article
Australian Group on Antimicrobial Resistance (AGAR) Australian Gram-negative Surveillance Outcome Program (GnSOP) Bloodstream Infection Annual Report 2024
Communicable diseases intelligence (2018), Vol.49
2025
PMID: 41248467
Abstract
The Australian Group on Antimicrobial Resistance (AGAR) performs regular period-prevalence studies to monitor changes in antimicrobial resistance in selected enteric gram-negative pathogens. From 1 January 2024 to 31 December 2024, fifty-five hospitals across Australia participated in the Australian Gram-negative Surveillance Outcome Program (GnSOP).
A total of 10,340 isolates, comprising Enterobacterales (9,376; 90.9%), Pseudomonas aeruginosa(804; 7.7%) and Acinetobacter species (160; 1.4%), were tested using commercial automated methods. The results were analysed using European Committee on Antimicrobial Susceptibility Testing (EUCAST) breakpoints (January 2025). Key resistances reported are to the third-generation cephalosporin ceftriaxone in 14.9% of Escherichia coli and 10.5% of Klebsiella pneumoniae complex isolates. Resistance rates to ciprofloxacin were 15.4% for E. coli; 9.7% for the K. pneumoniae complex; 3.8% for the Enterobacter cloacae complex; and 8.8% for P. aeruginosa. Resistance rates to piperacillin–tazobactam were 7.5%, 10.3%, 25.2%, and 13.6% for the same four species/complexes, respectively. Thirty-nine Enterobacteralesisolates from 38 patients were shown to harbour a carbapenemase gene: 21 with a blaNDM gene (blaNDM-5 [8]; blaNDM-1 [7]; blaNDM-7 [6]); eight with blaIMP-4; four with a blaOX A-181-like gene (blaOX A-181 [2]; blaOXA-484 [1]; blaOX A-1205[1]); three with a blaOXA-48-like gene (blaOXA-48 [2]; blaOXA-244); two with blaKPC-2; and one with blaNDM-5 + blaOXA-484. Carbapenemase genes were also detected in two P. aeruginosa isolates (blaNDM-1 [1]; blaGES-5 [1]).
Details
- Title
- Australian Group on Antimicrobial Resistance (AGAR) Australian Gram-negative Surveillance Outcome Program (GnSOP) Bloodstream Infection Annual Report 2024
- Authors/Creators
- Jan Bell - Australian Group on Antimicrobial ResistanceAlicia Fajardo LubianSally PartridgeThomas GottliebJennifer Robson - Sullivan Nicolaides PathologyJonathan IredellDenise Daley - Fiona Stanley HospitalGeoffrey Coombs
- Publication Details
- Communicable diseases intelligence (2018), Vol.49
- Publisher
- Australian Government. Department of Health, Disability and Ageing
- Identifiers
- 991005830208607891
- Copyright
- © 2025 Commonwealth of Australia as represented by the Department of Health, Disability and Ageing
- Murdoch Affiliation
- Centre for Biosecurity and One Health
- Language
- English
- Resource Type
- Journal article
UN Sustainable Development Goals (SDGs)
This output has contributed to the advancement of the following goals:
Metrics
4 Record Views